Bortezomib is a dipeptide boronic acid analogue with antineoplastic activity Bortezomib reversibly inhibits the 26S proteasome a large protease complex that degrades ubiquinated proteins It has a role as an antineoplastic agent a proteasome inhibitor a protease inhibitor and an antiprotozoal drug